Justin Chakma sold $1.4M of ARS Pharmaceuticals (SPRY)

Executed Nov 25 2024, disclosed Nov 27 2024, 2 days later.

Value, as filed

$1.4M

100,000 sh across 3 lots

Executed

Nov 25 2024

the trade date, as filed

Disclosed

Nov 27 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JC Justin Chakma Chief Business Officer profile →

Justin Chakma (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SPRY. The largest single filing was $1.5M of SPRY (166,380 sh across 2 lots, as filed), executed Nov 12 2025.

The name

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Justin Chakma in SPRY

SPRYSALE ARS Pharmaceuticals, Inc. $1.5M
166,380 sh across 2 lots
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.8M
144,605 sh across 2 lots
Exec Dec 12 2024
Filed Dec 13 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $658K
50,000 sh × $13.15
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $2.0M
144,640 sh across 3 lots
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.2M
90,000 sh across 2 lots
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET